Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse

Nature Genetics

Volumn 45, Issue 12, 2013, Pages 1494-1498

  Perez Andreu, Virginia ^a   Roberts, Kathryn G ^a   Harvey, Richard C ^b   Yang, Wenjian ^a   Cheng, Cheng ^a   Pei, Deqing ^a   Xu, Heng ^a   Gastier Foster, Julie ^c,d   Shuyu, E ^a   Lim, Joshua Yew Suang ^a,e   Chen, I Ming ^b   Fan, Yiping ^a   Devidas, Meenakshi ^f   Borowitz, Michael J ^g   Smith, Colton ^a   Neale, Geoffrey ^a   Burchard, Esteban G ^h   Torgerson, Dara G ^h   Klussmann, Federico Antillon ⁱ   Villagran, Cesar Rolando Najera ⁱ   Winick, Naomi J ^j   Camitta, Bruce M ^k   Raetz, Elizabeth ^l   Wood, Brent ^m   Yue, Feng ⁿ   Carroll, William L ^l   Larsen, Eric ^o   Bowman, W Paul ^p   Loh, Mignon L ^q   Dean, Michael ^r   Bhojwani, Deepa ^a   Pui, Ching Hon ^a   Evans, William E ^a   Relling, Mary V ^a   Hunger, Stephen P ^s   Willman, Cheryl L ^b   Mullighan, Charles G ^a   Yang, Jun J ^a   more..

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g DEPARTMENT OF PATHOLOGY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Unidad Nacional de Oncologia Pediatrica   (Guatemala)

^j UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^k MEDICAL COLLEGE OF WISCONSIN   (United States)

^l NEW YORK UNIVERSITY   (United States)

^m UNIVERSITY OF WASHINGTON   (United States)

ⁿ PENN STATE COLLEGE OF MEDICINE   (United States)

^o Maine Children's Cancer Program   (United States)

^p Cook Children's Medical Center ^*  (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r NATIONAL CANCER INSTITUTE   (United States)

^s CHILDREN S HOSPITAL COLORADO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; DEOXYRIBONUCLEASE I; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR GATA 3;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMERICAN INDIAN; ARTICLE; ASIAN; CANCER PROGNOSIS; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CRLF2 GENE; GENE DELETION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE MAP; HISPANIC; HISTONE METHYLATION; HUMAN; IKZF1 GENE; JAK GENE; LEUKEMIA RELAPSE; LEUKEMOGENESIS; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; PATHOGENESIS; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

CASE-CONTROL STUDIES; CHILD; GATA3 TRANSCRIPTION FACTOR; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INHERITANCE PATTERNS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; RISK;

EID: 84888311432     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2803     Document Type: Article

References (48)

1. Pui, C. H. & Evans, W. E. Treatment of acute lymphoblastic leukemia. N. Engl. J. Med. 354, 166-178 (2006). (Pubitemid 43076714)
2. Pui, C. H., Mullighan, C. G., Evans, W. E. & Relling, M. V. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there Blood 120, 1165-1174 (2012).
3. Hunger, S. P. et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the Children's Oncology Group. J. Clin. Oncol. 30, 1663-1669 (2012).
4. Stanulla, M. et al. Integrating molecular information into treatment of childhood acute lymphoblastic leukemia-a perspective from the BFM Study Group. Blood Cells Mol. Dis. 39, 160-163 (2007). (Pubitemid 47126931)
5. Biondi, A. et al. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. Lancet Oncol. 13, 936-945 (2012).
6. Den Boer, M. L. et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 10, 125-134 (2009).
7. Roberts, K. G. et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell 22, 153-166 (2012).
8. Harvey, R. C. et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood 116, 4874-4884 (2010).
9. Mullighan, C. G. et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N. Engl. J. Med. 360, 470-480 (2009).
10. Harvey, R. C. et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood 115, 5312-5321 (2010).
11. Loh, M. L. et al. Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project. Blood 121, 485-488 (2013).
12. Papaemmanuil, E. et al. Loci on 7p12. 2, 10q21. 2 and 14q11. 2 are associated with risk of childhood acute lymphoblastic leukemia. Nat. Genet. 41, 1006-1010 (2009).
13. Sherborne, A. L. et al. Variation in CDKN2A at 9p21. 3 influences childhood acute lymphoblastic leukemia risk. Nat. Genet. 42, 492-494 (2010).
14. Treviño, L. R. et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat. Genet. 41, 1001-1005 (2009).
15. Xu, H. et al. Novel susceptibility variants at 10p12. 31-12. 2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J. Natl. Cancer Inst. 105, 733-742 (2013).
16. Xu, H. et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J. Clin. Oncol. 30, 751-757 (2012).
17. Paulsson, K. et al. Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 107, 21719-21724 (2010).
18. Jones, A. V. et al. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat. Genet. 41, 446-449 (2009).
19. Olcaydu, D. et al. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat. Genet. 41, 450-454 (2009).
20. Kilpivaara, O. et al. A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms. Nat. Genet. 41, 455-459 (2009).
21. Yang, J. J. et al. Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat. Genet. 43, 237-241 (2011).
22. Fujiwara, T. et al. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol. Cell 36, 667-681 (2009).
23. Wei, G. et al. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity 35, 299-311 (2011).
24. Yagi, R., Zhu, J. & Paul, W. E. An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation. Int. Immunol. 23, 415-420 (2011).
25. Zhang, J. et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157-163 (2012).
26. Enciso-Mora, V. et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16. 1 (REL), 8q24. 21 and 10p14 (GATA3). Nat. Genet. 42, 1126-1130 (2010).
27. Pasquet, M. et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood 121, 822-829 (2013).
28. Hahn, C. N. et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat. Genet. 43, 1012-1017 (2011).
29. Davies, S. M. et al. Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 111, 2984-2990 (2008).
30. Huang, R. S. et al. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc. Natl. Acad. Sci. USA 104, 9758-9763 (2007). (Pubitemid 47175340)
31. Degner, J. F. et al. DNase I sensitivity QTLs are a major determinant of human expression variation. Nature 482, 390-394 (2012).
32. Borowitz, M. J. et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood 111, 5477-5485 (2008).
33. Shi, J. et al. Common variants on chromosome 6p22. 1 are associated with schizophrenia. Nature 460, 753-757 (2009).
34. Purcell, S. M. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752 (2009).
35. Troyer, J. L. et al. Genome-wide association study implicates PARD3B-based AIDS restriction. J. Infect. Dis. 203, 1491-1502 (2011).
36. Burchard, E. G. et al. Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am. J. Respir. Crit. Care Med. 169, 386-392 (2004). (Pubitemid 38134819)
37. Korn, J. M. et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat. Genet. 40, 1253-1260 (2008).
38. Pritchard, J. K., Stephens, M. & Donnelly, P. Inference of population structure using multilocus genotype data. Genetics 155, 945-959 (2000). (Pubitemid 30397141)
39. Mao, X. et al. A genomewide admixture mapping panel for Hispanic/Latino populations. Am. J. Hum. Genet. 80, 1171-1178 (2007). (Pubitemid 47579352)
40. Tibshirani, R., Hastie, T., Narasimhan, B. & Chu, G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. USA 99, 6567-6572 (2002). (Pubitemid 34526173)
41. Liu, E. Y., Li, M., Wang, W. & Li, Y. MaCH-admix: genotype imputation for admixed populations. Genet. Epidemiol. 37, 25-37 (2013).
42. Pruim, R. J. et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26, 2336-2337 (2010).
43. Chen, I. M. et al. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. Blood 119, 3512-3522 (2012).
44. Andersen, P. K. & Perme, M. P. Pseudo-observations in survival analysis. Stat. Methods Med. Res. 19, 71-99 (2010).
45. Duan, S. et al. Genetic architecture of transcript-level variation in humans. Am. J. Hum. Genet. 82, 1101-1113 (2008).
46. Spielman, R. S. et al. Common genetic variants account for differences in gene expression among ethnic groups. Nat. Genet. 39, 226-231 (2007). (Pubitemid 46184354)
47. Ernst, J. et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473, 43-49 (2011).
48. Zhou, X. et al. The Human Epigenome Browser at Washington University. Nat. Methods 8, 989-990 (2011).